LIU Chaoyu, HU Jihong, GUO Chunguang, ZHOU Pingqiu, LIU Juan, YUAN Liping. A study on the etiology background of cerebral palsy in children[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 36-40. DOI: 10.7619/jcmp.202022010
Citation: LIU Chaoyu, HU Jihong, GUO Chunguang, ZHOU Pingqiu, LIU Juan, YUAN Liping. A study on the etiology background of cerebral palsy in children[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 36-40. DOI: 10.7619/jcmp.202022010

A study on the etiology background of cerebral palsy in children

More Information
  • Received Date: July 25, 2020
  • Available Online: December 21, 2020
  • Published Date: December 02, 2020
  • Objective To analyze the related high-risk factors of cerebral palsy(CP)in children. Methods A total of 163 CP children in Hunan Children's Hospital from June 2018 to June 2019 were selected as study group, and 326 healthy children with physical examination in Outpatient Department at the same time were selected as control group. The questionnaire was used to collect the prenatal, intrapartum and postpartum conditions in both groups. The prenatal, intrapartum and postpartum factors of CP were analyzed by single factor analysis. Multivariate Logistic regression analysis was performed on the variables with statistical significance. Meanwhile, chromosomal test of CP children was completed. Results In 163 CP children, 30 cases of chromosome polymorphism were detected, the detection rate of heterochromatin was 18.40%, and among which polymorphism in chromosome 9 was the most(10.43%). Pregnancy age over 35 years old, family history of similar diseases, history of adverse pregnancy and childbirth, history of contact with harmful substances, intrauterine distress, multiple pregnancy and complications were the prenatal factors of CP in children(P<0.05), preterm delivery, asphyxia and dystocia were the intrapartum factors of CP(P<0.05), low birth weight, hypoxic-ischemic encephalopathy and hypoglycemia were the postpartum factors of CP in children(P<0.05), and the independent risk factors of CP in children were pregnant age over 35 years old, family history of CP and similar diseases, multiple pregnancy, comorbidity, premature delivery, neonatal asphyxia and low birth weight(P<0.05). According to the Odds Ratio(OR)value, - the effect of risk factors for CP in children were comorbidity, pregnant age over 35 years old, premature delivery, low birth weight, family history of CP and similar diseases, multiple pregnancy and neonatal asphyxia in decending order of influence power. Conclusion Prenatal factors are the main causes of CP in children, and are also the important causes of diseases during labor and neonatal period. The incidence of CP is related to genetic factors. In clinical practice, we should strengthen the health care and health management for pregnant women, improve the precise gene detection, accurately assess the risk of CP, and reduce the incidence of CP in children by timely implementation of early intervention.
  • KOY A, TIMMERMANN L. Deep brain stimulation in cerebral palsy: Challenges and opportunities[J]. Eur J Paediatr Neurol, 2017, 21(1): 118-121.
    黄小玲, 陈景汉, 刘汇团, 等. 333例脑瘫儿童病因高危因素分析[J]. 国际医药卫生导报, 2019, 25(8): 1199-1202.
    PENNINGTON L, LOMBARDO E, STEEN N, et al. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy[J]. Int J Lang Commun Disord, 2017, 53(1): 182-195.
    朱庆文, 倪玉飞, 王婧, 等. 10例以脑发育不良为主要特征的脑瘫患儿的遗传学病因分析[J]. 中华医学遗传学杂志, 2019, 36(3): 229-233.
    李晓捷. 《脑瘫指南及定义、分型、诊断标准修订》[C] //第六届全国儿童康复、第十三届全国小儿脑瘫康复学术会议暨国际学术交流会议. 2014.
    MELLER C H, IZBIZKY G H, OTAÑO L. Prenatal Factors in Cerebral Palsy[J]. N Engl J Med, 2015, 373(23): 2288-2289.
    龙滨, 陈琳, 尹艳艳. 探析孕妇妊娠晚期B族链球菌感染对妊娠结局及新生儿的影响[J]. 中国实用医药, 2017, 12(35): 70-72.
    LINDSAY K L, BUSS C, WADHWA P D, et al. The Interplay between Maternal Nutrition and Stress during Pregnancy: Issues and Considerations[J]. Ann Nutr Metab, 2017, 70(3): 191-200.
    代立静. 关于妊娠期孕妇营养状况与胎儿发生出生缺陷的相关性探究[J]. 大家健康旬刊, 2017, 11(1): 193-193.
    LUNDGREN C, BRUDIN L, WANBY A S, et al. Ante- and intrapartum risk factors for neonatal hypoxic ischemic encephalopathy[J]. J Matern Fetal Neonatal Med, 2017, 31(12): 1595-1601.
    提鑫婧, 林梦梦, 刘扬, 等. 居住环境因素对出生缺陷影响的Meta分析[J]. 中国儿童保健杂志, 2019, 27(4): 411-413

    , 428.
    赵茹茹, 刘铭, 段涛. 孕激素预防双胎妊娠自发性早产的研究进展[J]. 中华围产医学杂志, 2017, 20(1): 61-64.
    YIN Y, LI C, XU C, et al. Intestinal obstruction due to congenital malrotation complicating a multiple pregnancy: A rare case report[J]. J Pak Med Assoc, 2017, 67(2): 308-310.
    TUPIKOV V A, KOLMAKOVA T S, SHAMIK V B, et al. [Results of a clinical and genealogical analysis of pedigrees of children with cerebral palsy in the population of Rostov region] [J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2017, 117(7): 80-85.
    夏开德, 周晓涛, 杨雪, 等. 贵州地区儿童患者染色体多态性的细胞遗传学分析[J]. 中国优生与遗传杂志, 2018, 26(6): 43-45.
    朱佳鹏, 何慧燕, 梁灼健, 等. 染色体多态性与生殖异常的相关性分析[J]. 中华医学遗传学杂志, 2018, 35(6): 921-922.
    LERER I, SAGI M, MEINER V, et al. Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy[J]. Hum Mol Genet, 2005, 14(24): 3911-3920.
    PASHMDARFARD M, AMINI M, HASSANI M A. Participation of Iranian Cerebral Palsy Children in Life Areas: A Systematic Review Article[J]. Iran J Child Neurol, 2017, 11(1): 1-12.
    PAULSEN M E, DIETZ R M. Antenatal magnesium for preterm delivery reduces risk of cerebral palsy among surviving very preterm infants[J]. Acta Paediatr, 2018, 107(1): 175.
  • Related Articles

    [1]SUN Mengxiong, YANG Shuai, ZHI Xiongli, YUE Yanjun. Expression and significance of serum complements and blood lipid indexes in patients with coronary heart disease after atorvastatin treatment[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 71-75. DOI: 10.7619/jcmp.20222514
    [2]LUO Liya, LIU Cuiqing, GENG Lijie, LIU Shanshan, ZHANG Wei, ZHANG Shuai. Effect of different doses of atorvastatin on vascular endothelial function in elderly patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 103-106, 111. DOI: 10.7619/jcmp.20211235
    [3]ZHANG Jianhui, WANG Lin, CAO Saisai. Effect of atorvastatin calcium in the treatment of unstable angina pectoris and its impact on inflammatory response[J]. Journal of Clinical Medicine in Practice, 2019, 23(23): 73-75, 79. DOI: 10.7619/jcmp.201923022
    [4]GU Weiqing. Clinical effect of ginkgo biloba leaf tablets combined with atorvastatin on the treatment of atherosclerotic plaque formation[J]. Journal of Clinical Medicine in Practice, 2018, (1): 35-37. DOI: 10.7619/jcmp.201801011
    [5]JU Yanling, ZANG Xuelian, ZHAO Xu. Effect of amlodipine atorvastatin calcium tablet on IMT, PV, TNF, CRP, and blood lipid level of coronary heart disease and high blood pressure patients complicated with carotid atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2017, (1): 14-18. DOI: 10.7619/jcmp.201701004
    [6]PENG Fu, HUANG Zaiwen, LIANG Yaowu. Effect of atorvastatin on blood lipids levels and cognitive function of patients with different stages of vascular cognitive impairment[J]. Journal of Clinical Medicine in Practice, 2016, (9): 29-31,40. DOI: 10.7619/jcmp.201609008
    [7]LI Xiaoli, LI Fei. Efficacy of atorvastatin and amlodipine besylate for coronary heart disease complicated by cerebral infarction and its effect on blood lipids[J]. Journal of Clinical Medicine in Practice, 2015, (15): 8-10. DOI: 10.7619/jcmp.201515003
    [8]DING Yongj uan, LYU Juan, GUO Jing, BIAN Yun. Influence of atorvastatin intensive treatment on blood lipid and the level of serum hs-CRP and MMP-9 in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2014, (17): 12-14,21. DOI: 10.7619/jcmp.201417004
    [9]LI Wei. Factors of ACS atorvastatin on blood lipid levels, serum inflammatory[J]. Journal of Clinical Medicine in Practice, 2013, (15): 56-58. DOI: 10.7619/jcmp.201315020
    [10]NIU Yu-ling, GENG Xue-fan. Effects of different uses of rosuvastatin in lipid lowering on acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2011, (15): 19-21,36. DOI: 10.3969/j.issn.1672-2353.2011.15.007
  • Cited by

    Periodical cited type(4)

    1. 余晓伊, 格日勒. 不同他汀类药物对急性心肌梗死患者血管内皮功能、心脏功能的影响. 中国现代医生. 2020(06): 90-93 .
    2. 程乾堃. 不同剂量他汀类药物在急性心肌梗死早期患者中的应用效果比较. 中国当代医药. 2020(10): 50-52+59 .
    3. 杨柳, 熊晓波, 李艳. 血尿酸、Hcy、T细胞和血脂在急性冠脉综合征患者中的表达水平及相关性分析. 川北医学院学报. 2020(04): 687-690 .
    4. 王燕, 王小艳, 刘丽伟, 王玉宏. 依折麦布联合瑞舒伐他汀治疗低密度脂蛋白胆固醇未达标的急性冠状动脉综合征的临床研究. 现代药物与临床. 2018(12): 3161-3166 .

    Other cited types(0)

Catalog

    Article views (399) PDF downloads (14) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return